Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
The Journal of Organic Chemistry|September 20, 1996
Application of Arene-Ruthenium Chemistry to a Formal Total Synthesis of OF 4949 IIIAnthony J. Pearson, Penglie Zhang, Kieseung LeeDevelopment (Cambridge, England)|April 11, 2014
CXCR7 prevents excessive CXCL12-mediated downregulation of CXCR4 in migrating cortical interneuronsPhilipp Abe, Wiebke Mueller, Dagmar Schütz, et al.Chemical & Pharmaceutical Bulletin|September 2, 2009
Design, synthesis and discovery of 1-(2-(6-Chloro-3-methylsulfonyl)-naphthyl)-1H-pyrazole-5-carboxylamides as highly potent factor Xa inhibitorsZhaozhong Jon Jia, Robert Murry Scarborough, Penglie Zhang, et al.Immunology Letters|January 22, 2013
CCR9 inhibition does not interfere with the development of immune tolerance to oral antigensMatthew J Walters, Karen Ebsworth, Timothy J Sullivan, et al.Bioorganic & Medicinal Chemistry Letters|March 20, 2009
Anthranilamide-based N,N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SARPenglie Zhang, Liang Bao, Jingmei Fan, et al.Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Inhibitory effect of carboxylic acid group on hERG bindingBing-Yan Zhu, Zhaozhong J Jia, Penglie Zhang, et al.Nature Communications|January 19, 2017
Structural basis of ligand interaction with atypical chemokine receptor 3Martin Gustavsson, Liwen Wang, Noortje van Gils, et al.Current Drug Metabolism|October 15, 2025
Mass Balance and Metabolic Profiling of Avacopan, a Selective C5a Receptor 1 Antagonist, in Healthy HumansYang Song, Shichang Miao, Ruiping Zhao, et al.Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P(1) structure-activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamidesZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitorsPenglie Zhang, Jingmei F Zuckett, John Woolfrey, et al.Pageof 4